Bridger Management’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Bridger Management’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-16,000	Closed	-$222K	–	42
2022 Q3	$222K	Hold	16,000	–	–	0.07%	42
2022 Q2	$644K	Hold	16,000	–	–	0.15%	40
2022 Q1	$1.68M	Hold	16,000	–	–	0.28%	45
2021 Q4	$1.84M	Hold	16,000	–	–	0.24%	38
2021 Q3	$6.06M	Hold	16,000	–	–	0.71%	35
2021 Q2	$6.53M	Hold	16,000	–	–	0.61%	39
2021 Q1	$7.63M	Buy	+16,000	New	+$8.71M	0.71%	37

Other funds holding NEXI

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Allen Operations New York $670M AUM 26.43% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

Bridger Management's NEXI Position: Q4 2022 in Review

Bridger Management sold out of NexImmune, Inc. Common Stock (NEXI) in Q4 2022, closing a stake of 16,000 shares — an estimated $222K sold.

Bridger Management first reported a position in NEXI in Q1 2021 and held it in 7 quarters. The position peaked at $7.63M in Q1 2021. 29 funds tracked by Wall St. Rank hold NEXI as of Q4 2022.

Bridger Management reported no remaining NexImmune, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Bridger Management sold 16,000 NexImmune, Inc. Common Stock shares in Q4 2022, an estimated $222K.
Bridger Management first reported a position in NexImmune, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
Bridger Management's NexImmune, Inc. Common Stock position peaked at $7.63M in Q1 2021.
29 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q4 2022.

Based on Bridger Management's 13F filing for Q4 2022, filed 15 Feb 2023.